Issued Patents 2018
Showing 1–8 of 8 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10123982 | Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy | Martin E. Sanders | 2018-11-13 |
| 10092535 | Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones | Martin E. Sanders | 2018-10-09 |
| 10039731 | Treatment of cancer with specific RXR agonists | — | 2018-08-07 |
| 10034845 | Autoimmune disorder treatment using RXR agonists | Ethan Dmitrovsky, Elizabeth Nowak, Randolph J. Noelle | 2018-07-31 |
| 10004709 | Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy | Martin E. Sanders | 2018-06-26 |
| 10004708 | Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy | Martin E. Sanders | 2018-06-26 |
| 9907768 | Receptor subtype and function selective retinoid and rexinoid compounds in combination with immune modulators for cancer immunotherapy | Martin E. Sanders | 2018-03-06 |
| 9877941 | Treatment of nervous system disorders using combinations of RXR agonists and thyroid hormones | Martin E. Sanders | 2018-01-30 |